Literature DB >> 30607667

Cryoballoon ablation of atrial fibrillation is effectively feasible without previous imaging of pulmonary vein anatomy: insights from the 1STOP project.

A Sagone1, S Iacopino2, P Pieragnoli3, G Arena4, R Verlato5, G Molon6, G Rovaris7, A Curnis8, W Rauhe9, M Lunati10, G Senatore11, M Landolina12, G Allocca13, S De Servi14, C Tondo15.   

Abstract

BACKGROUND: Pulmonary vein isolation by cryoablation (PVI-C) is a standard therapy for the treatment of atrial fibrillation (AF); however, PVI-C can become a challenging procedure due to the anatomy of the left atrium and pulmonary veins (PVs). Importantly, the utility of imaging before the procedure is still unknown regarding the long-term clinical outcomes following PVI-C. The aim of the analysis is to evaluate the impact of imaging before PVI-C on procedural data and AF recurrence.
METHODS: Patients with paroxysmal AF underwent an index PVI-C. Data were collected prospectively in the framework of 1STOP ClinicalService® project. Patients were divided into two groups according to the utilization of pre-procedural imaging of PV anatomy (via CT or MRI) or the non-usage of pre-procedural imaging.
RESULTS: Out of 912 patients, 461 (50.5%) were evaluated with CT or MRI before the PVI-C and denoted as the imaging group. Accordingly, 451 (49.5%) patients had no pre-procedural imaging and were categorized as the no imaging group. Patient baseline characteristics were comparable between the two cohorts, but the ablation centers that comprised the imaging group had fewer PVI-C cases per year than the no imaging group (p < 0.001). The procedure, fluoroscopy, and left atrial dwell times were significantly shorter in the no imaging cohort (p < 0.001). The rates of complications were significantly greater in the imaging group compared to the no imaging group (6.9% vs. 2.7%; p = 0.003); this difference was attributed to differences in transient diaphragmatic paralysis. The 12-month freedom from AF was 76.2% in the imaging group and 80.0% in the no imaging group (p = 0.390).
CONCLUSIONS: In our analysis, PVI-C was effective regardless of the availability of imaging data on PV anatomy.

Entities:  

Keywords:  AF recurrences; Cardio imaging; Cryoballoon; Outcomes; Paroxysmal atrial fibrillation

Year:  2019        PMID: 30607667     DOI: 10.1007/s10840-018-0500-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  2 in total

1.  Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real-world global setting: Results from the Cryo AF Global Registry.

Authors:  Kyoung Ryul Julian Chun; Ken Okumura; Fernando Scazzuso; Young Keun On; Fred J Kueffer; Kendra M Braegelmann; Surinder Kaur Khelae; Fawzia Al-Kandari; Csaba Földesi
Journal:  J Arrhythm       Date:  2021-01-25

2.  Impact of pulmonary vein ovality index on cooling kinetics and acute success of atrial fibrillation ablation with the third-generation cryoballoon catheter.

Authors:  Milena Stachyra; Marcin Szczasny; Adam Tarkowski; Magdalena Mianowana; Katarzyna Wojewoda; Katarzyna Wysokinska; Piotr Blaszczak; Andrzej Głowniak
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-11-17       Impact factor: 1.426

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.